Stephen P. Holmes net worth and biography

Stephen Holmes Biography and Net Worth

Stephen P. Holmes serves as Non-Executive Chairman of our Board of Directors, after previously serving as Chairman and Chief Executive Officer of Wyndham Worldwide since July 2006. With the spin-off of Wyndham Hotels & Resorts from Wyndham Worldwide, Mr. Holmes also currently serves as Chairman of the Board of Directors of Wyndham Destinations. Prior to the creation of Wyndham Worldwide, Mr. Holmes served in various leadership positions in the hospitality and financial services industries, including Vice Chairman and member of the Board of Directors of Cendant Corporation, where he oversaw Cendant’s hotel franchise, vehicle rental, timeshare development, timeshare exchange and vacation rental business. Mr. Holmes was also Executive Vice President and Chief Financial Officer of HFS, and Managing Director of The Blackstone Group. He began his career as a Certified Public Accountant with Deloitte and Touche LLP.

What is Stephen P. Holmes' net worth?: The estimated net worth of Stephen P. Holmes is at least $45.39 million as of December 1st, 2020. Mr. Holmes owns 619,301 shares of Wyndham Hotels & Resorts stock worth more than $45,388,570 as of May 8th. This net worth evaluation does not reflect any other investments that Mr. Holmes may own. Learn More about Stephen P. Holmes' net worth.
How do I contact Stephen P. Holmes?: The corporate mailing address for Mr. Holmes and other Wyndham Hotels & Resorts executives is 22 SYLVAN WAY, PARSIPPANY NJ, 07054. Wyndham Hotels & Resorts can also be reached via phone at (973) 753-6000 and via email at [email protected]. Learn More on Stephen P. Holmes' contact information.
Has Stephen P. Holmes been buying or selling shares of Wyndham Hotels & Resorts?: Stephen P. Holmes has not been actively trading shares of Wyndham Hotels & Resorts within the last three months. Learn More on Stephen P. Holmes' trading history.
Who are Wyndham Hotels & Resorts' active insiders?: Wyndham Hotels & Resorts' insider roster includes Michele Allen (CFO), Paul Cash (General Counsel), Lisa Checchio (CMO), Mary Falvey (Insider), Stephen Holmes (Director), Scott LePage (Insider), Nicola Rossi (CAO), and Scott Strickland (Insider). Learn More on Wyndham Hotels & Resorts' active insiders.
Are insiders buying or selling shares of Wyndham Hotels & Resorts?: During the last year, insiders at the sold shares 3 times. They sold a total of 207,479 shares worth more than $15,241,587.44. The most recent insider tranaction occured on May, 1st when CEO Geoffrey A Ballotti sold 196,279 shares worth more than $14,399,027.44. Insiders at Wyndham Hotels & Resorts own 2.8% of the company. Learn More about insider trades at Wyndham Hotels & Resorts.
Information on this page was last updated on 5/1/2024.

Stephen P. Holmes Insider Trading History at Wyndham Hotels & Resorts

Stephen P. Holmes Buying and Selling Activity at Wyndham Hotels & Resorts

Wyndham Hotels & Resorts Company Overview

Wyndham Hotels & Resorts, Inc. operates as a hotel franchisor in the United States and internationally. It operates through Hotel Franchising and Hotel Management segments. The Hotel Franchising segment licenses its lodging brands and provides related services to third-party hotel owners and others. The Hotel Management segment provides full-service international managed business services. It is also involved in the guest loyalty program business. The company's hotel brand portfolios include Super 8, Days Inn, Travelodge, Microtel, Howard Johnson, La Quinta, Ramada, Baymont, AmericInn, Wingate, Wyndham Alltra, Wyndham Garden, Ramada Encore, Hawthorn, Trademark Collection, TRYP, Wyndham, Wyndham Grand, WaterWalk Extended Stay by Wyndham, Dazzler, Esplendor, Dolce, Vienna House, and Registry Collection. Wyndham Hotels & Resorts, Inc. was incorporated in 2017 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $72.56

$72.42

$73.99

50 Day Range

MA: $74.66

$69.31

$79.74

2 Week Range

Now: $72.56

$63.69

$81.73

Volume

468,148 shs

Average Volume

692,187 shs

Market Capitalization

$5.85 billion

P/E Ratio

25.73

Dividend Yield

2.08%

Beta

1.33

Fidelity, Bezos, Goldman Bet Big on Tiny Biotech

From Behind the Markets | Ad

Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.

Don't miss out on the "next Ozempic" >>>